Ovarian or Uterine Cancer Diagnosis

Right Specialist, Right Now

The biggest factor in how your treatment will end is making the right decision about where your treatment should begin. Many hospitals and physicians treat women's cancers, but it's a challenge to find one place with the skill and expertise to do it all. At Cedars-Sinai Women's Cancer Program we have more experience, more options and more positive outcomes. 

If you are a woman with ovarian or uterine cancer, your road to survivorship should not be traveled alone. You need a cancer specialist by your side — one person who leads the charge for your care. At Cedars-Sinai, a cancer specialist will be there — from diagnosis to surgery to chemotherapy — guiding you on your road to recovery.

Often, for women treated elsewhere, the typical journey can be challenging: She's diagnosed by her gynecologist. She's referred to a surgeon. Then, after surgery, she meets with an oncologist who manages her chemotherapy and radiation. Throughout this ordeal, she has had three or more physicians – equally competent and skilled — but she is left with having multiple people coordinating her care.

At Cedars-Sinai, we approach women's cancer differently. One of our physicians confirms the diagnosis. As a gynecologic surgeon who is a fellowship-trained surgical expert, she or he will then perform the surgery. After the surgery, the same physician will guide your plan for chemotherapy or radiation and will be with you and your family throughout the journey.

Ovarian and Uterine Cancer Diagnosis

Ovarian cancer is often referred to as the "cancer that whispers" because its symptoms are vague, and a diagnosis is often not made until the cancer is advanced. Known for being the fifth-leading cause of cancer deaths among women, it often goes undetected until it has spread into the pelvis and abdomen. No effective screening test is currently available for the early detection of ovarian cancer, but that hasn't stopped our physicians from researching ways to detect it at an earlier stage, when a cure is more likely.

Uterine cancer is the most common gynecologic cancer in the United States, diagnosed in approximately 40,000 women each year. It often generates early symptoms of abnormal vaginal bleeding, which allows for diagnosis in its early and curable stage. However, death rates from uterine cancer have been on the rise, more than doubling over the last five years.

Quality of Care

Quality measures are important indicators for measuring the success of a program and its physicians. The specialists at Cedars-Sinai Women's Cancer Program perform the most uterine and ovarian cancer procedures in Los Angeles. Our physicians have the expertise, skill and treatment options available to help patients live longer. In fact, our five-year survival rate for Stage 3 ovarian cancer is well above the national average.

How You Can Help

Research for Her is a large data registry — clinical trial program — that focuses on finding treatments and cures for cancers that specifically impact women including breast, ovary, uterine/endometrial, cervical and vulvar cancer. Open to all women over the age of 18 with or without a prior history of cancer, Research for Her is a way to be a part of efforts to improve early detection of cancers, better target treatments and explore treatment options for individuals with cancer.

Team Approach

Andrew Li, MD talks about what makes Cedars-Sinai unique for patients

Featured Video

Breakthroughs in Ovarian Cancer
Video provided courtesy of Lifescript.